Safflower yellow pigment and Sanqi Panax notoginseng in the treatment of acute cerebral infarction: a systematic review, meta-analysis, and cost-effectiveness analysis

Abstract

Background: Sanqi Panax notoginseng injection and safflower yellow injection were Chinese traditional medicine injections for the treatment of cardiovascular diseases and were used to treat acute cerebral infarction patients in public hospital widely. The aim of this study was to compare and analyze the published reports of efficacy and safety of Sanqi Panax notoginseng injection and safflower yellow injection for the treatment of acute cerebral infarction. The cost-effectiveness of these drug formulations was also evaluated.

Clinical characteristics of heavy alcohol consumption in young and middle-aged acute cerebral infarction: A 12-month follow-up study

“…Traditional Chinese medicine injections, such as Safflower Yellow Injection, are commonly employed in ACI treatment. Safflower Yellow Injection and associated combination therapies demonstrate notable safety and minimal adverse reactions [ 12 ]. However, emphasizing primary and secondary prevention remains paramount in the comprehensive management of stroke-related diseases.…”